Multiple Real-World Data Sources in a Bayesian Framework to Inform Long-Term Survival Estimates of Mosunetuzumab in Patients with Follicular Lymphoma

Multiple Real-World Data Sources in a Bayesian Framework to Inform Long-Term Survival Estimates of Mosunetuzumab in Patients with Follicular Lymphoma

Abstract Introduction Patients with follicular lymphoma (FL) receiving third-line or later (3L +) therapy have long survival, which can make estimating long-term overall survival (OS) from trial data challenging. The objective of this study was to estimate long-term OS for mosunetuzumab from the GO2...

Full description

Bibliographic Details
Main Authors: Javier Sanchez Alvarez, Mahmoud Jaber, Marie-Hélène Blanchet Zumofen
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-10-01
Series:Oncology and Therapy
Subjects:
Bayesian analysis
Follicular lymphoma
Mosunetuzumab
Real-world data
Survival
Third-line therapy
Online Access:https://doi.org/10.1007/s40487-023-00245-4

Internet

https://doi.org/10.1007/s40487-023-00245-4

Similar Items